Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04102410
Other study ID # 1708238
Secondary ID 2018-A01613-52
Status Completed
Phase N/A
First received
Last updated
Start date September 30, 2019
Est. completion date April 4, 2022

Study information

Verified date June 2022
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cardiac rehabilitation includes aerobic and anaerobic training adapted to cardiovascular pathology for which cardiac rehabilitation is prescribed. It is essential to adapt the content of these cardiac rehabilitation sessions to optimize aerobic and anaerobic performance and quality of life. Improvement of the first ventilatory threshold is one of the main objectives since it illustrates the adaptation of the patient to submaximal exercise, typical of everyday life. The research laboratory "Autonomous Nervous System - Epidemiology, Physiology, Engineering, Health" (SPA-EPIS) has an international expertise in training optimization in top-athletes. He have shown the importance of the relationship between the power-force-velocity profile and athletes performances.


Description:

In this sudy, each patient has a force and a velocity that can be optimized with training to achieve maximum power. This optimization can be evaluated through a force-velocity profile, measured from an only sprint on a cycloergometer. The hypothesis that force-velocity profile could be used in cardiac rehabilitation in coronary patients to induce a force-velocity balance adapted through personalized sessions and regular medical follow-up. This prospective, controlled, randomized and open label study will attempt to evaluate further the relevance of force or velocity training based on the initial force-velocity profile of coronary patients included in the cardiac rehabilitation program in the University Hospital of Saint-Etienne.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date April 4, 2022
Est. primary completion date April 4, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Acute coronary syndrome treated within the last 6 months - Medical revascularization (angioplasty ± stenting) or surgical (coronary artery bypass) - During initial effort test: Maximum aerobic power= 60 watts for women and = 80 watts for men - Patient affiliated or beneficiary to social security - Signed informed consent Exclusion Criteria: - Significant co-morbidities limited practice of physical activity - Inability to submit to medical monitoring of the program - Patient deprived of liberty or patient under guardianship - Pregnant woman

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Sprints
Two sprints of 8 seconds on a cycle ergometer will be performed for determine Force/Velocity Profile (FVP). Realized at inclusion and 2 months after.
Vertical jumps
Two vertical jumps will be performed. Height of theses vertical jumps will be measured by application "My jump 2" to determine muscle power. Realized at inclusion and 2 months after.
Questionary Short Form-12 (SF-12)
Questionary Short Form-12 (SF-12) will be performed to evaluate quality of life. It is composed of 12 questions. Realized at inclusion and 2 months after.
Device:
activity actigraph
Activity actigraph will be wearing by patient during 7 consecutive days. It measures the level of physical activity and the sedentary lifestyle of patients. Realized at inclusion and 2 months after.
Other:
Program composed of two 2 training strategies
Program composed of two 2 training strategies according to the initial Force/Velocity Profile (FVP) will be realized at the inclusion. There are : Strategy "experimental-speed": speed training strategy for subjects with a force-speed profile (PFV) in favour of force Strategy "experimental-force": force training strategy for subjects with a force-speed profile (PFV) in favour of speed.
Program of usual practice
Program composed of training in force and speed independently of the initial Force/Velocity Profile (FVP).

Locations

Country Name City State
France Chu Saint-Etienne Saint-Étienne

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne Laboratoire SNA-EPIS - Université Jean Monnet

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary volume of oxygen consumed (VO2) (in ml/min/kg) at the first ventilatory threshold (SV1) Change in VO2 (volume of oxygen in ml/min/kg) at the first ventilatory threshold (SV1) during a Cardio-Pulmonary Exercise Test (CPET). Months: 0 and 2
Secondary VO2 max (volume of oxygen maximum in ml/min/kg) Comparison VO2 max (volume of oxygen maximum in ml/min/kg) during a Cardio-Pulmonary Exercise Test (CPET). Months: 0 and 2
Secondary Power at first ventilatory threshold (SV1) Comparison value of power at first ventilatory threshold (SV1) during a Cardio-Pulmonary Exercise Test (CPET). Months: 0 and 2
Secondary Maximum aerobic power (in watt) Comparison maximum aerobic power (in watt) during a Cardio-Pulmonary Exercise Test (CPET). Months: 0 and 2
Secondary Voluntary muscle power (in kg) during a static muscle testing on quadriceps Comparison voluntary muscle power (in kg) during a static muscle testing on quadriceps. Months: 0 and 2
Secondary Voluntary muscle power (in kg) during a dynamic muscle testing on quadriceps Comparison voluntary muscle power (in kg) during a dynamic muscle testing on quadriceps. Months: 0 and 2
Secondary Value of muscular endurance (in min) during a static muscle testing on quadriceps Comparison value of muscular endurance (in min) during a static muscle testing on quadriceps. Months: 0 and 2
Secondary Value of muscular endurance (in min) during a dynamic muscle testing on quadriceps Comparison value of muscular endurance (in min) during a dynamic muscle testing on quadriceps. Months: 0 and 2
Secondary Standard Deviation of the Normal R-R interval (SDNN) index Measured by holter electrocardiogram during 24 hours. Months: 0 and 2
Secondary BaroReflex Sensitivity (BRS) (in ms/mmHg) Measured by baroreflex. Months: 0 and 2
Secondary Physical activity (in Metabolic Equivalent of Task (MET)-min/week) Assessment of Physical activity (in Metabolic Equivalent of Task (MET)-min/week).
Measured by activity actigraph.
Month: 0
Secondary Sedentary life (in hour/day) Assessment of Sedentary life (in hour/day). Measured by activity actigraph. Month: 0
Secondary SF-12 questionnaire score The SF-12 is a self-questionnaire to assess the quality of life. This tool is an abbreviated version of the "Medical Outcomes Study Short-Form General Health Survey" (SF-36) contains only 12 items out of 36 with minimum score 0 (bad quality life) and maximum score at 100 (good quality life). Months: 0 and 2
See also
  Status Clinical Trial Phase
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT05412927 - AngelMed Guardian® System PMA Post Approval Study
Completed NCT02750579 - Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes? N/A
Enrolling by invitation NCT03342131 - Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome N/A
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Enrolling by invitation NCT04676100 - International CR Registry
Completed NCT03590535 - 5th Generation cTnT in ED ACS
Recruiting NCT05437900 - INSIGHTFUL-FFR Clinical Trial Phase 4
Completed NCT05551429 - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Terminated NCT04316481 - IDE-ALERTS Continued Access Study N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT04852146 - Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
Active, not recruiting NCT02892903 - In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? N/A
Completed NCT04077229 - Piloting Text Messages to Promote Positive Affect and Physical Activity N/A
Not yet recruiting NCT02871622 - BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM N/A
Completed NCT02944123 - Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) Phase 3
Active, not recruiting NCT02922140 - The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit N/A
Completed NCT02673437 - Rivaroxaban ACS Specialist Cohort Event Monitoring Study
Terminated NCT02620202 - Aiming Towards Evidence Based Interpretation of Cardiac Biomarkers in Patients Presenting With Chest Pain